VSee Health, Inc.
VSEE
$0.55
-$0.03-5.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.67% | 98.07% | 104.90% | 170.29% | 131.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.67% | 98.07% | 104.90% | 170.29% | 131.10% |
| Cost of Revenue | 234.81% | 92.77% | 278.33% | 252.79% | 19.08% |
| Gross Profit | -25.55% | 104.44% | 50.64% | 137.60% | 186.17% |
| SG&A Expenses | 4.61% | 122.16% | 234.27% | 309.31% | 218.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.64% | 133.67% | 245.69% | 296.29% | 163.19% |
| Operating Income | -76.76% | -220.18% | -1,504.37% | -840.50% | -338.75% |
| Income Before Tax | 99.46% | -11.27% | -4,262.34% | -1,328.84% | -16,124.44% |
| Income Tax Expenses | -- | 100.27% | -- | -52.73% | 103.77% |
| Earnings from Continuing Operations | 99.46% | -292.33% | -4,276.58% | -104.85% | -54,588.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.46% | -312.13% | -6,404.78% | -102.37% | -48,478.92% |
| EBIT | -76.76% | -220.18% | -1,504.37% | -840.50% | -338.75% |
| EBITDA | -174.26% | -128.70% | -1,004.05% | -638.00% | -94.00% |
| EPS Basic | 99.51% | -33.03% | -2,527.00% | -28.10% | -32,118.92% |
| Normalized Basic EPS | -106.81% | 61.18% | -2,260.00% | -420.07% | 844.65% |
| EPS Diluted | 99.51% | -33.03% | -2,527.00% | -28.10% | -32,118.92% |
| Normalized Diluted EPS | -106.81% | 61.18% | -2,260.00% | -420.07% | 844.65% |
| Average Basic Shares Outstanding | 9.76% | 209.72% | 159.88% | 58.01% | 50.80% |
| Average Diluted Shares Outstanding | 9.76% | 209.72% | 159.88% | 58.01% | 50.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |